Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Teva Launches Epiduo Forte Gel's Generic Version in US

12/01/2021 | 09:56am EST


© MT Newswires 2021
All news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED
01/18Teva settles shareholder lawsuit over generic drug pricing for $420 mln
RE
01/18Teva settles shareholder lawsuit over generic drug pricing for $420 mln
RE
01/18Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Res..
BU
01/18IMMUNEERING CORP : Change in Directors or Principal Officers, Financial Statements and Exh..
AQ
01/18Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M...
AQ
01/06Immuneering Reports Compelling Preclinical Data on IMM-1-104 in NRAS Mutant Melanoma Mo..
AQ
01/04Teva to Present at the 40th Annual J.P. Morgan Healthcare Conference
BU
01/03Immuneering Appoints Rimma Steinhertz, Ph.D., PMP as Vice President, Project and Allian..
AQ
2021Thinking about buying stock in SuperCom, Teva Pharmaceutical, Future Fintech Group, Spr..
PR
2021ADRs End Mostly Higher; Teva Down on Opioid Verdict
DJ
More news
Analyst Recommendations on TEVA PHARMACEUTICAL INDUSTRIES LIMITED
More recommendations
Financials (USD)
Sales 2021 16 194 M - -
Net income 2021 954 M - -
Net Debt 2021 21 746 M - -
P/E ratio 2021 11,2x
Yield 2021 -
Capitalization 9 409 M 9 409 M -
EV / Sales 2021 1,92x
EV / Sales 2022 1,78x
Nbr of Employees 37 736
Free-Float -
Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Teva Pharmaceutical Industries Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 8,53 $
Average target price 10,47 $
Spread / Average Target 22,8%
EPS Revisions
Managers and Directors
Kåre Schultz President, Chief Executive Officer & Director
Eli Kalif Chief Financial Officer & Executive Vice President
Sol J. Barer Chairman
Hafrun Fridriksdottir President-Global Generics Research & Development
Eric Drapé Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED6.49%9 409
JOHNSON & JOHNSON-2.01%441 302
ROCHE HOLDING AG-8.68%304 745
PFIZER, INC.-11.02%294 900
ABBVIE INC.-1.71%235 287
ELI LILLY AND COMPANY-13.31%217 093